Zum Inhalt

Annals of Hematology

Ausgabe 1/2026

Inhalt (34 Artikel)

Hypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care?

  • Open Access
  • Brief Report

Francesco Tarantini, Corinne Contento, Ernesto Vigna, Vera Carluccio, Giuseppina Greco, Crescenza Pasciolla, Lucia Ciuffreda, Giovanni Rossi, Marina Aurora Urbano, Alessandro D’Ambrosio, Lara Aprile, Vito Pier Gagliardi, Mario Delia, Immacolata Attolico, Paola Carluccio, Vincenzo Federico, Antonella Bruzzese, Nicola Di Renzo, Massimo Gentile, Giuseppe Tarantini, Anna Mele, Attilio Guarini, Lorella Maria Antonia Melillo, Angelo Michele Carella, Domenico Pastore, Ferdinando Frigeri, Alessandro Maggi, Cosimo Cumbo, Giorgina Specchia, Pellegrino Musto, Francesco Albano

Vitamin D deficiency in sickle cell disease: a neglected comorbidity in Tunisia

  • Open Access
  • Research

Mariem Othmani, Yessine Amri, Yosr Jouini, Faida Ouali, Siwar Chelbi, Sondess Hadj Fredj, Rym Dabboubi, Taieb Messaoud

Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial

  • Open Access
  • Research

Bin Jiang, Jian Li, Ligen Liu, Xin Du, Hao Jiang, Jianda Hu, Xiaoxi Zeng, Taishi Sakatani, Masanori Kosako, Yaru Deng, Vladimir Ivanov, Sergey Bondarenko, Lily Wong Lee Lee, Archrob Khuhapinant, Elena Martynova, Nahla Hasabou, Jamie Jung-Hee An, Jianxiang Wang

Chronic portal hypertension following inotuzumab ozogamicin in a low-risk patient: a case of overriding baseline risk and long-term management

  • Open Access
  • Case Report

Jinchun Wu, Jingjing Cao, Lu Gao, Min Yang, Jie Shao, Ying Zhang, Xiaowei Xu, Yu Cai, Yu Wei, Xianmin Song, Liping Wan

Luspatercept for the treatment of transfusion-dependent non-severe aplastic anemia

  • Open Access
  • Correspondence

Xinru Jia, Rudan Zheng, Yaonan Hong, Hangping Ge, Yingying Shen, Yuhong Zhou, Xiawan Yang, Dijiong Wu

Long-Term endocrine outcomes with special emphasis on the gonadal impact of acute lymphoblastic leukemia treatment in females

  • Open Access
  • Research

Hasan Karakaş, Gürkan Tarçın, Elvan Bayramoğlu, Hande Turan, Suheyla Ocak, Volkan Turan, Olcay Evliyaoğlu, Tiraje Tiraje, Hilmi Apak, Oya Ercan

Does differentiation syndrome in newly diagnosed acute promyelocytic leukemia warrant systemic antifungal therapy? A real-world clinical study

  • Open Access
  • Correspondence

Yuhan Jiang, Chen Luo, Huiling Yan, Lijun Zhu, Xing Hu, Lei Xue, Juan Tong, Changcheng Zheng

Ponatinib for CML patients in routine clinical practice: the PONDEROSA study

  • Open Access
  • Research

Thomas Schenk, Christian Fabisch, Thomas Ernst, Philipp Ernst, Susanne Saussele, Daniela Žáčková, Jiří Mayer, Hana Klamová, Andreas Hochhaus

Whole-exome sequencing identifies a CD38 variant in a Chinese family with hodgkin’s lymphoma

  • Open Access
  • Research

Xi Chen, Li Xie, Wanchun Wu, Ming Jiang, Yi Cui, Liqun Zou

MMSA-1 is regulated by Wnt/TCF4 and involved in multiple myeloma progression and invasion via RAS/RAF signaling pathway

  • Open Access
  • Research

Shan Meng, Hailing Liu, Liufang Gu, Jin Wang, Jianli Wang, Wanhong Zhao

Retrospective cohort evaluation of renal involvement in non-HIV castleman disease patients from a single academic center in Beijing, China

  • Open Access
  • Research

Hongtao Ling, Lihong Wang, Wei Wang, Xiaoying Yang, Wenqiong Wang, Shuanglian Xie, Yiming Zhao, Shujing Guo, Weiwei Xie, Zhizhen Lai, Huihui Liu, Xiaodi Yang, Xiaojuan Yu, Yujun Dong

Evaluating inflammatory markers in distinguishing polycythemia Vera from secondary polycythemia: a prospect for novel diagnostic marker

  • Open Access
  • Research

Mohammad Navid Khaksari, Kimia Oraei Sajjadi, Fatemeh Arianmanesh, Hossein Ayatollahi, Samaneh Boroumand-Noughabi

The evolving landscape of platelet therapy: risks, innovations, and clinical judgment

  • Open Access
  • Review

Ali Mushtaq, Moises Salgado de la Mora, Al-Homam Dabaliz, Zaher Otrock, Deborah Tolich, Moises Auron

Portraits of clonal hematopoiesis in DNMT3A/TET2/ASXL1-mutant myelodysplastic neoplasms and acute myeloid leukemia

  • Open Access
  • Correspondence

Shyam A. Patel, Salwa Khedr, Lloyd Hutchinson, Yiyu Xie, Maria R. Khouri, Jan Cerny, Jonathan M. Gerber

Unraveling the many faces of angioimmunoblastic T-cell lymphoma: clinical, pathological, and molecular heterogeneity

  • Open Access
  • Review

Jia-Ping Chen, Peng Ke, Xiao Qiu, Qiu-Yuan Xian, Jing-Song Wu, Chun Feng, Hui-Jun Li, Yang Wang, Ji-Hao Zhou

Integrating FLT3-ITD molecular features with clinical risk factors improves risk stratification in acute myeloid leukemia

  • Open Access
  • Research

Kainan Zhang, Xiaohang Ma, Xiaoxuan Lu, Guorui Ruan, Fangfang Wei, Hao Jiang, Yingjun Chang, Xiaojun Huang, Xiaosu Zhao

Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney disease

  • Open Access
  • Case Report

Christina Brummer, Katja Evert, Felix Keil, Jakob Schmidt, Matthias Grube, Wolfgang Herr, Markus Radsak, Stephanie Mayer

Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study

  • Open Access
  • Research

Fabrizio Cavalca, Roberto Latagliata, Novella Pugliese, Giuseppe Alberto Palumbo, Nicola Polverelli, Pellegrino Musto, Giulia Benevolo, Filippo Branzanti, Ambra Di Veroli, Eugenia Accorsi Buttini, Alessia Ripamonti, Ivan Civettini, Laura Montelisciani, Laura Antolini, Carlo Gambacorti-Passerini, Francesca Palandri, Elena Maria Elli

Next-generation CAR-T therapy for acute myeloid leukemia: bridging innovation with clinical translation

  • Open Access
  • Review

Xumeng Zhao, Xi Ming, Jiaying Wu, Xiaojian Zhu, Yi Xiao

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms

  • Open Access
  • Research

Marine Demoy, Maxence Bauvais, Agathe Vely, Thomas Nicol, Jérémie Riou, Hortense Le Jeanne, Aurélien Bauduin, Hubert Rambaud, Françoise Boyer, Franck Geneviève, Agathe Boussaroque, Marie-Christine Copin, Valérie Ugo, Corentin Orvain, Damien Luque Paz

SF3B1 mutation as a predictive biomarker for luspatercept efficacy in myeloproliferative neoplasms and MDS/MPN: a clinical study

  • Open Access
  • Correspondence

Tingting Cui, Jie Gong, Xinyu Zhang, Juan Zhang, Na Wei, Wenqi Zheng, Minghui Duan

Efficacy and safety of mini-cvd combined with venetoclax and azacitidine in philadelphia chromosome-negative acute leukemia of ambiguous lineage: a single-center retrospective study

  • Open Access
  • Research

Yan Li, Yue Shang, Kaiqi Liu, Yuntao Liu, Dong Lin, Jinsong He, Jiesi Li, Yanping Zeng, Hui Wei, Zhangsong Yan, Yingchang Mi

Lycorine inhibits the proliferation of acute myeloid leukemia cells by upregulating the expression of THBS1

  • Open Access
  • Research

Lunbi Wu, Peng Liu, Bowen Jiang, Xiaodong Zhang, Enliang Zhao, Jingying Zhao, Fangxu Zhu, Hongxin Xu, Kuo Shi, Baiyu Jian

Paediatric blastic plasmacytoid dendritic cell neoplasm: a single-centre case series of 18 children and review of the literature

  • Open Access
  • Research

Zhi-xiao Zhang, Lin Zhang, Ai-dong Lu, Le-ping Zhang, Yue-ping Jia, Fengrong Wang, Hui-min Zeng

Plitidepsin in combination with dexamethasone (ADMYRE trial) versus an external control arm of pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma

  • Open Access
  • Research

Heinz Ludwig, Evangelos Terpos, Mario Boccadoro, Sara Martínez, Carmen Kahatt, Javier Jiménez, Antonio Nieto, Sonia Extremera, Javier Gómez, Vicente Alfaro, Ruthanna Davi, Xiang Yin, María Victoria Mateos

Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy

  • Open Access
  • Research

Lingxiao Xing, Wenrui Yang, Huihui Fan, Jianping Li, Yufei Zhao, Weiru Liang, Jun Shi, Fengkui Zhang, Xin Zhao

Survival outcomes and adverse prognostic factors of Langerhans cell histiocytosis: a 40-year experience from a single tertiary center in Thailand

  • Open Access
  • Research

Gamchai Atirattanachai, Natsaruth Songthawee, Pornpun Sripornsawan, Umaporn Yam-ubon, Thirachit Chotsampancharoen

Contraceptives in chronic lymphocytic leukemia (CLL): a narrative review

  • Open Access
  • Review

Rafal Al-Shibly, Nabeel Qassim, Khalil Alfarsi, Salem AlShemmari, Mohammed Yassin

Neuro-related gene signatures predict prognosis in diffuse large B-Cell lymphoma and uncover TRPV2-mediated tumor microenvironment regulation

  • Open Access
  • Research

Boyuan Su, Siyu Qian, Yukai Duan, Feiyang Zong, Wanyue Zhao, Yue Zhang, Mingzhi Zhang, Yunfei Song, Xudong Zhang, Qingjiang Chen

BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia

  • Open Access
  • Brief Report

Florian Robert, Cherif Badja, Soraya Boushaki, Andrea Degasperi, Yasin Memari, Sophie Momen, Theodoros I. Roumeliotis, Zuza Kozik, Malgorzata Gozdecka, Jyoti Choudhary, George Vassiliou, Gene CC Koh, Serena Nik-Zainal

Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study

  • Open Access
  • Research

Yunfei Lv, Yanan Zhu, Chunmei Yang, Xiang Zhang, Xuewu Zhang, Juying Wei, Xingnong Ye, Gaixiang Xu, Liping Mao, Wenyuan Mai, Min Yang, Jiejing Qian, Hongyan Tong, Jie Jin, Wenjuan Yu

Elevated IGF1R and abnormal methylated IGF1R in immune thrombocytopenia

  • Open Access
  • Research

Xiaojuan Zhu, Na Gao, Xiaoyan Li, Ting Yuan, Yanxia Liu, Qingmin Yao, Feng Zhang, Ningning Shan

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Fokale Salvage-Therapie bei lokalem Prostatakrebsrezidiv langfristig wirksam

Bei einem nach Radiotherapie lokal rezidivierten Prostatakarzinom sind fokale Salvage-Therapien mit einer guten Prognose verbunden: Das krebsspezifische Zehn-Jahres-Überleben ist einem retrospektiven Vergleich zufolge ebenso hoch wie nach Salvage-Prostatektomie.

ICI-induzierte Dermatitis: Upadacitinib als vielversprechende Therapieoption

Immunvermittelte Hautreaktionen gehören zu den häufigsten Nebenwirkungen von Immun‑Checkpoint‑Inhibitoren. Eine offene Phase‑2‑Studie untersuchte den JAK‑1‑Inhibitor Upadacitinib bei schwerer ICI‑assoziierter Dermatitis. Die Hautsymptome gingen rasch zurück, schwerwiegende therapieassoziierte Nebenwirkungen wurden nicht beobachtet.

Extrapulmonale Befunde beim Lungenkrebs-Screening – Krebsverdacht gerechtfertigt?

Der Umgang mit Zufallsentdeckungen ist ein vieldiskutiertes Thema im Zusammenhang mit dem Low-Dose-CT-Screening auf Lungenkrebs. Eine Studie hat sich nun speziell mit inzidentellen Befunden befasst, die auf ein extrapulmonales Malignom verdächtig sind.

KI-Chatbots bieten 24/7-Sprechstunde für Patienten

Medizinischen Rat von Chatbots auf der Basis sogenannter künstlicher Intelligenz haben laut Umfragen bereits knapp die Hälfte aller Erwachsenen schon einmal eingeholt. Welche Chancen und Risiken birgt das?

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Eine Person kratzt sich am Rücken über der Schulter/© ryanking999 / stock.adobe.com (Symbolbild mit Fotomodell), Mann erhält einen CT-Scan /© Mark Kostich / stock.adobe.com (Symbolbild mit Fotomodell)